Interfacing a commercial drug-interaction program with an automated medical record

Area of Science:

• Pharmacology
• Health Informatics
• Medical Software Development

Background:

• Current drug-interaction software lacks interoperability with existing electronic health records (EHRs).
• This forces healthcare professionals to manually re-enter medication lists, increasing the risk of errors and inefficiency.
• The proliferation of diverse EHR systems makes it challenging for software vendors to create universal interfaces.

Purpose of the Study:

• To describe a method for interfacing a commercially available drug-interaction software package with a preexisting automated medical record.
• To demonstrate how greater access to drug-interaction data can enhance EHR systems.
• To improve the integration of clinically relevant drug interaction information into patient records.

Main Methods:

• Development of an interface logic to connect drug-interaction software with an existing automated medical record.
• Utilizing a commercially available drug-interaction software package as a case study.
• Modifying existing automated records to incorporate drug-interaction data.

Main Results:

• Successful creation of an interface between drug-interaction software and a preexisting automated medical record.
• Demonstrated feasibility of integrating drug interaction alerts directly within EHRs.
• Reduced need for duplicate medication list entry.

Conclusions:

• Interfacing drug-interaction software with automated medical records is achievable and beneficial.
• Increased vendor access to drug-interaction data can significantly improve EHR functionality.
• This integration enhances patient safety and clinical workflow efficiency by providing timely drug interaction information.